Oncology Nursing in MDS: Risk Stratification, Anemia & Adverse Event Management | Free CME

📖 Course Title: Nursing Perspectives in Myelodysplastic Syndromes: Risk-Adapted Therapy and Symptom Management 🎓Faculty: Ilene Galinsky, BSN, MSN, NPc | Selena Carmona, MS, MPAS, PA-C | Kristi Orbaugh, MSN, NP, AOCNP 🔗 Access the Entire Course & Earn CE Credit: https://mli.link/yt-26015 📖 Course Description: Oncology nurses and NPs: advance your expertise in myelodysplastic syndromes (MDS) care with this comprehensive, evidence-based nursing education program presented live at ONS Congress® in San Antonio, TX. Myelodysplastic syndromes (MDS) are complex hematologic malignancies that demand individualized, risk-adapted treatment approaches and robust supportive care strategies. As the treatment landscape for MDS evolves rapidly — particularly for managing MDS-related anemia and cytopenias — oncology nurses must stay current with the latest evidence-based guidelines and emerging therapeutic options. In this 90-minute interactive MLI Dialogues session, expert faculty and patient testimonials guide you through: ✔ MDS Risk Stratification — Key clinical, cytogenetic, and molecular biomarkers used to classify lower-risk MDS (LR-MDS) and higher-risk MDS (HR-MDS), including IPSS-R scoring and its role in treatment decision-making ✔ Anemia Management in LR-MDS — Current and emerging therapeutic options, including erythropoiesis-stimulating agents, luspatercept, and transfusion management, with the latest clinical data and guideline updates ✔ Adverse Event Monitoring & Management — Practical, nursing-led strategies for identifying and managing treatment-related adverse events and disease-related complications across MDS care settings ✔ Shared Decision-Making in MDS — How oncology nurses can empower patients with LR-MDS and HR-MDS through effective education, counseling, and shared decision-making frameworks that improve adherence and quality of life This activity is designed for US-based oncology nurses, nurse practitioners (NPs), and physician assistants (PAs) caring for patients with MDS and other hematologic malignancies. 🔔 Subscribe for more oncology nursing education, hematology updates, and evidence-based clinical resources.    / @mlieducation   Learning Objectives: -Explain key clinical factors and cytogenetic/molecular biomarkers used in risk stratification and management of patients with lower-risk myelodysplastic syndrome (LR MDS) and higher-risk myelodysplastic syndrome (HR MDS)  -Apply current and emerging therapeutic options for the management of anemia in patients with LR MDS, based on the latest data and evidence-based guidelines   -Develop monitoring and management strategies for treatment-related adverse events and disease-related complications in patients with LR MDS   -Implement nursing-led approaches to educate and counsel patients with LR MDS and equip them for productive shared decision-making encounters  Earn up to 1.5 hrs ANCC, ILNA, AAPA, IPCE, MIPS credits/contact hours. Access this Course On-Demand & Earn CE Credit Here: https://mli.link/yt-26015 📅 Published On: 6/15/26 ⏳ Expiration Date: 6/14/27 This activity is provided by MLI This activity is supported by educational grants from Bristol Myers Squibb and Geron Corporation. Link to Activity Front Matter & Commercial Support Statement: https://mli.link/yt-26015 #MDSNursing #MyelodysplasticSyndromes #OncologyNursing #HematologyNursing #LowerRiskMDS #ONSCongress #OncologyNP #HematologicMalignancies #NursingEducation #RiskAdaptedTherapy #MLI #MLIeducation #ContinuingEducation #CE #CEcredit #CME 📢 Follow Us on Social Media:   / mlieducation     / mlieducation     / mlieducation   https://x.com/mlieducation   / mlieducation   https://www.threads.net/@mlieducation https://bsky.app/profile/mlieducation...